DRUGSwww.epgonline.orgDISEASE KNOWLEDGE CENTRESwww.epgonline.orgGUIDELINESwww.epgonline.orgCLINICAL TRIALSwww.epgonline.orgMEDICAL NEWSwww.epgonline.orgLINKSwww.epgonline.org
Members Login
How to use the
Email

Password



EPG News Feed Medical News
EPG Online Disease Knowledge Centres Feed Disease Knowledge
Recent UK Drug Updates Drug Updates
EPG Search
Frequent Searches:
Search
Languages

Browse Other Languages
YouTube - Featured Content

Want to submit or suggest content for the epgonline.org YouTube Clinical channel?
Contact us here

epgonline.org is not responsible for content on any 3rd party website

GIST - understanding, management, diagnosis and treatment information. CML - understanding, management, diagnosis and treatment information. Thrombosis - understanding, management, diagnosis and treatment information. Alzheimer's Disease, understanding, management, diagnosis and treatment information
Are you a Doctor or Healthcare Professional? Authorise Viewing

Please register to access disease diagnosis, patient management, physician tools.

By viewing the content of this web page you are both confirming your status as a healthcare professional and agreeing to our terms of use.

Change language Current language database: United Kingdom

A  |  B  |  C  |  D  |  E  |  F  |  G  |  H  |  I  |  J  |  K  |  L  |  M
N  |  O  |  P  |  Q  |  R  |  S  |  T  |  U  |  V  |  W  |  X  |  Y  |  Z

Medicine information : TENIF (angina)
 
Drug class description :  Cardioselective b-blockers (beta- blockers) / calcium-channel blockers (class II calcium antagonists).
Generic Name :  Atenolol, nifedipine - angina
Drug description :  Reddish brown capsules marked with TENIF and 'S' logo.
Presentation :  Capsules, atenolol 50mg, sustained-release nifedipine 20mg.
Indications :  Angina prophylaxis, where a beta- blocker or calcium antagonist blocker or calcium antagonist proves inadequate.
Adult Dosage :  1 twice daily.
Child Dosage :  Not recommended.
Contra Indications :  Bradycardia, uncontrolled heart failure, 2nd or 3rd degree heart block, cardiogenic shock. Pregnancy, lactation. Known hypersensitivity to either component, hypotension, metabolic acidosis, severe peripheral arterial circulatory disturbances, sick sinus syndrome, untreated phaeochromocytoma, severe renal impairment, aortic stenosis, unstable angina or during or within one month of a myocardial infarction, acute attacks of angina.
Special Precautions :  Cardiac conduction defects or poor cardiac reserve, COAD, renal or hepatic impairment, diabetes, anaesthesia, asthma. May be used with care in patients already treated with a beta-blocker and/ or whose signs of heart failure have been controlled. Thyrotoxicosis. Prinzmetal's angina. Atopy, asthenic symptoms, cerebrovascular insufficiency, first degree heart block.
Interactions :  Quinidine, cardiodepressants, rifampicin, clonidine withdrawal, disopyramide, verapamil, diltiazem, digoxin, hypoglycaemic agents, cimetidine, grapefruit juice, anaesthetics, adrenaline, ibuprofen, indomethacin. Nifedipine may cause falsely increased spectrophotometric values of urinary vanillylmandelic acid; measurement with HPLC is unaffected.
Adverse Reactions :  Flushing, headache, dizziness, dry eyes, skin rash, oedema, hypersensitivity type jaundice, gingival hyperplasia, purpura. Reports of impaired sperm function in single cases of in vitro fertilisation due to nifedipine (see SPC for further information). Also, confusion, agranulocytosis, urticaria, exanthema, dermatitis, systemic allergic reactions. Gastrointestinal disturbances, fatigue, bradycardia, heart failure deterioration, postural hypotension, cold extremities, precipitation of heart block, intermittent claudication, Raynaud's phenomenon, mood changes, nightmares, psychoses and hallucinations, sleep disturbances, dry mouth, elevations of transaminase levels, hepatic toxicity, alopecia, psoriaform skin reactions, exacerbations of psoriasis, paraesthesia, bronchospasm, visual disturbances, palpitations, tachycardia, gravitational oedema, disturbances of liver function, pruritus, erythromelalgia, myalgia, tremor, gynaecomastia, increased frequency of micturition, exacerbation of angina pectoris.
Manufacturer :  AstraZeneca
Drug Availability :  (POM)
Free registration to access disease diagnosis, patient management, physician tools.

Only registered users have access to the full EPG Online Knowledge Base including drug search tools, interactive disease Knowledge Centres via the EPG Knowledge Library - with clinical and evidence based physician and research tools, MiMedia (build your own clinical media collection with everything from key opinion leader essays to mode of action videos and other multi-media content), the EPG Survey panel, health news updates and much much more.

Already Registered?

Please log-in now using our member login box.

Not a member?

Don't worry, registration is quick and FREE! We welcome all Healthcare professionals, doctors, nurses and medical students.

Register today to have full access to a wealth of drug data, educational and evidence based interactive guides across all major therapeutic areas, disease management, and clinical tools.

As a practicing Healthcare professional, you can also opt-in to join our market research panel – www.epgsurvey.com – and get paid for sharing your expert clinical opinions!

REGISTER today it only takes a minute! and it's FREE

Having problems?

Use our forgotten password facility or email us at: contact@epgonline.org

What's New!
Try EPG Mobile
Latest News
Disease Knowledge Centres

EPG Survey Become a member of
the new EPG Survey Panel.
Your opinions matter, get paid for them! Join Now!